Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 4
1989 10
1990 7
1991 12
1992 19
1993 25
1994 14
1995 23
1996 15
1997 16
1998 13
1999 18
2000 29
2001 26
2002 36
2003 36
2004 35
2005 45
2006 34
2007 26
2008 45
2009 48
2010 54
2011 49
2012 68
2013 54
2014 39
2015 39
2016 38
2017 23
2018 37
2019 33
2020 43
2021 32
2022 18
Text availability
Article attribute
Article type
Publication date

Search Results

968 results
Results by year
Filters applied: . Clear all
Page 1
Post-transplant lymphoproliferative disorders.
Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Dharnidharka VR, et al. Nat Rev Dis Primers. 2016 Jan 28;2:15088. doi: 10.1038/nrdp.2015.88. Nat Rev Dis Primers. 2016. PMID: 27189056 Review.
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in many early-onset cases, through multiple mechanisms. ...Treatment of established disease includes reductio …
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV
Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD, Preiksaitis JK; AST Infectious Diseases Community of Practice. Allen UD, et al. Clin Transplant. 2019 Sep;33(9):e13652. doi: 10.1111/ctr.13652. Epub 2019 Jul 23. Clin Transplant. 2019. PMID: 31230381
Recent epidemiologic studies report a decrease in early EBV-positive (+) PTLD and an increase in late EBV-negative (-) PTLD. Pre-transplant EBV-seronegativity and primary EBV infection, often from donor-transmitted infection, are an important risk fact …
Recent epidemiologic studies report a decrease in early EBV-positive (+) PTLD and an increase in late EBV-negative (-) PTLD. P …
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Huang YH, Zhang CZ, Huang QS, Yeong J, Wang F, Yang X, He YF, Zhang XL, Zhang H, Chen SL, Zheng YL, Deng R, Lin CS, Yang MM, Li Y, Jiang C, Kin-Wah Lee T, Ma S, Zeng MS, Yun JP. Huang YH, et al. J Hepatol. 2021 Apr;74(4):838-849. doi: 10.1016/j.jhep.2020.10.037. Epub 2020 Nov 17. J Hepatol. 2021. PMID: 33212090 Free article.
BACKGROUND & AIMS: Little is known about Epstein-Barr virus (EBV)-associated intrahepatic cholangiocarcinoma (EBVaICC) because of its rarity. ...RESULTS: EBVaICC accounted for 6.6% of ICCs and was associated with EBV latency type I infection and clonal EBV
BACKGROUND & AIMS: Little is known about Epstein-Barr virus (EBV)-associated intrahepatic cholangiocarcinoma (EBVaICC) because of …
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE; EBV-HLH Rituximab Study Group. Chellapandian D, et al. Br J Haematol. 2013 Aug;162(3):376-82. doi: 10.1111/bjh.12386. Epub 2013 May 21. Br J Haematol. 2013. PMID: 23692048 Free PMC article.
Haemophagocytic lymphohistiocytosis (HLH) is a life threatening complication of Epstein-Barr virus (EBV) infection. The anti-CD20 antibody rituximab depletes B cells, leading to improved outcomes for patients with EBV-associated B-lymphoproliferative disorder …
Haemophagocytic lymphohistiocytosis (HLH) is a life threatening complication of Epstein-Barr virus (EBV) infection. The anti-CD20
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leithäuser M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S; German PTLD Study Group; European PTLD Network. Trappe R, et al. Lancet Oncol. 2012 Feb;13(2):196-206. doi: 10.1016/S1470-2045(11)70300-X. Epub 2011 Dec 13. Lancet Oncol. 2012. PMID: 22173060 Clinical Trial.
METHODS: In this international multicentre open-label phase 2 trial, treatment-naive adult solid-organ transplant recipients diagnosed with CD20-positive PTLD who had failed to respond to upfront immunosuppression reduction received four courses of rituximab (375 mg/m(2) i …
METHODS: In this international multicentre open-label phase 2 trial, treatment-naive adult solid-organ transplant recipients diagnosed with …
Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk.
Läderach F, Münz C. Läderach F, et al. Microorganisms. 2021 Oct 21;9(11):2191. doi: 10.3390/microorganisms9112191. Microorganisms. 2021. PMID: 34835317 Free PMC article. Review.
The strongest synergy among them exists between the MHC class II haplotype and infection with the Epstein Barr virus (EBV), especially symptomatic primary EBV infection (infectious mononucleosis) and elevated EBV-specific antibodies. In this review, we will s …
The strongest synergy among them exists between the MHC class II haplotype and infection with the Epstein Barr virus (EBV), especiall …
Posttransplant lymphoproliferative disease after lung transplantation.
Neuringer IP. Neuringer IP. Clin Dev Immunol. 2013;2013:430209. doi: 10.1155/2013/430209. Epub 2013 Mar 5. Clin Dev Immunol. 2013. PMID: 23533455 Free PMC article. Review.
Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives du …
Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral …
Epstein-Barr virus-infected plasma cells in periodontitis lesions.
Olivieri CV, Raybaud H, Tonoyan L, Abid S, Marsault R, Chevalier M, Doglio A, Vincent-Bugnas S. Olivieri CV, et al. Microb Pathog. 2020 Jun;143:104128. doi: 10.1016/j.micpath.2020.104128. Epub 2020 Mar 9. Microb Pathog. 2020. PMID: 32165332
Growing evidence supports that the Epstein-Barr virus (EBV) is a putative periodontal pathogen, but little is known regarding EBV behavior in periodontitis. ...EBV-infected PCs formed high-density clusters within the infiltrate and along the periodontal epith …
Growing evidence supports that the Epstein-Barr virus (EBV) is a putative periodontal pathogen, but little is known regarding EBV
Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
Fernández-Menéndez S, Fernández-Morán M, Fernández-Vega I, Pérez-Álvarez A, Villafani-Echazú J. Fernández-Menéndez S, et al. J Neurol Sci. 2016 Feb 15;361:213-9. doi: 10.1016/j.jns.2016.01.013. Epub 2016 Jan 6. J Neurol Sci. 2016. PMID: 26810546 Review.
EBV infection persists in B-cells during the lifetime of the host and can modulate their function. ...Several mechanisms of pathogenesis, including a direct and indirect function of infected B cells, have been postulated in inflammation and neurodegeneration. A relationshi
EBV infection persists in B-cells during the lifetime of the host and can modulate their function. ...Several mechanisms of pathogene
Epstein-Barr virus infection and posttransplant lymphoproliferative disorder.
Green M, Michaels MG. Green M, et al. Am J Transplant. 2013 Feb;13 Suppl 3:41-54; quiz 54. doi: 10.1111/ajt.12004. Am J Transplant. 2013. PMID: 23347213 Free article. Review.
EBV disease and its associated PTLD is more frequently seen when primary EBV infection occurs after transplant, a common scenario in pediatric SOT recipients. ...The future development of standards for management based on EBV viral load and routine monitoring
EBV disease and its associated PTLD is more frequently seen when primary EBV infection occurs after transplant, a common scena
968 results